A*STAR’s Bioprocessing Technology Institute (BTI) and GSK Biologicals SA Belgium have recently sealed an agreement to collaborate in three vaccine and adjuvant system related research projects. This partnership aims to bring new approaches to vaccine development and production.
With biologics becoming increasingly profitable with growth in sales doubling that of traditional pharmaceuticals, BTI’s work on characterizing [...]

US pharmaceutical giant GlaxoSmithKline (GSK) brings good news to Singapore, beyond the Ribena and Panadol (yes, they are the ones bringing you your familiar consumer health care products, vaccines and prescription medicine).
On 26 January 2008, during Prime Minister Lee Hsien Loong’s visit to its Jurong plant, GSK announced that it will invest another $100 million [...]